E
Evolus, Inc.
EOLS · NASDAQ · Healthcare · 537M
Closing price
$7.73
-0.90% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-26.6×
Free cash flow yieldFCF yield
-10.2%
Return on equityROE
223.5%
Operating margin
-12.7%
Net debt / EBITDAbalance-sheet strength
-4.5×
Interest coverage
-1.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.